ABLA
LLY icon

Alan B. Lancz & Associates’s Eli Lilly LLY Stock Holding History

Alan B. Lancz & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Hold
1,415
– – 1.48% 15
2026
Q1 		$1.3M Sell
1,415
-155
-10% -$157K 1.26% 17
2025
Q4 		$1.69M Hold
1,570
– – 1.48% 13
2025
Q3 		$1.2M Buy
1,570
+40
+3% +$29.8K 1.08% 19
2025
Q2 		$1.19M Hold
1,530
– – 1.19% 18
2025
Q1 		$1.26M Sell
1,530
-25
-2% -$20.8K 1.35% 14
2024
Q4 		$1.2M Sell
1,555
-175
-10% -$145K 1.22% 19
2024
Q3 		$1.53M Buy
1,730
+25
+1% +$22.5K 1.41% 14
2024
Q2 		$1.54M Buy
+1,705
New +$1.36M 1.53% 14
2023
Q4 		$1.03M Sell
1,775
-350
-16% -$204K 1.09% 18
2023
Q3 		$1.14M Hold
2,125
– – 1.3% 17
2023
Q2 		$997K Hold
2,125
– – 1.07% 19
2023
Q1 		$730K Hold
2,125
– – 0.76% 29
2022
Q4 		$768K Hold
2,125
– – 0.78% 28
2022
Q3 		$687K Hold
2,125
– – 0.82% 30
2022
Q2 		$701K Sell
2,125
-225
-10% -$67.5K 0.69% 32
2022
Q1 		$673K Sell
2,350
-56
-2% -$14.4K 0.59% 39
2021
Q4 		$665K Buy
+2,406
New +$610K 0.58% 47

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alan B. Lancz & Associates's LLY Position: Q2 2026 in Review

Alan B. Lancz & Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 1,415 shares worth $1.7M. The position accounts for 1.48% of the portfolio, ranked #15.

Alan B. Lancz & Associates first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alan B. Lancz & Associates held 1,415 shares of Eli Lilly worth $1.7M as of Q2 2026.
  • Alan B. Lancz & Associates left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.48% of Alan B. Lancz & Associates's portfolio in Q2 2026, its #15 holding.
  • Alan B. Lancz & Associates first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alan B. Lancz & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.